Rob Andrews, Chief Executive Officer of the Health Transformation Alliance

Rob Andrews, CEO of the Health Transformation Alliance (HTA), joins Elizabeth Caselo on the Becker's Payer Issues podcast to discuss the future of U.S. healthcare, emphasizing a shift from cost-based competition to value-driven outcomes. Drawing from his 24-year tenure in the U.S. House of Representatives and personal experiences as a father and spouse of a physician, Andrews critiques the current healthcare system’s inefficiencies and highlights how employers are increasingly bypassing legacy carriers due to lack of responsiveness and data transparency. He argues that the future of Medicare Advantage lies not in annual rate bumps, but in consumer experience, accessibility, and demonstrable health outcomes. Andrews envisions a competitive landscape where new, agile players—whether startups or non-traditional entrants—can disrupt the status quo by focusing on consumer-centric care, data-driven decision-making, and innovative models like hybrid insurance for high-cost gene therapies. He stresses that trust with employers is earned through transparency, reliability, and solving real operational problems—not flashy promises. The conversation also explores the looming tsunami of gene and cell therapy claims, which could strain current insurance models. Andrews predicts a hybrid system where high-cost, high-impact treatments are managed through fully insured, risk-bearing products with capped premiums, while routine care remains in self-funded plans. He urges industry leaders to celebrate healthcare’s triumphs—like neonatal survival and cancer cures—while fixing systemic flaws. Ultimately, he calls for a cultural shift: rewarding frontline caregivers and patient advocates over revenue maximizers, and building a system that delivers care as efficiently and reliably as modern e-commerce.